Oncoinvent ASA (0RU5) Ratios
Oncoinvent ASA Ratios
GB:0RU5's free cash flow for Q2 2026 was $-69.32M. For the 2026 fiscal year, GB:0RU5's free cash flow was decreased by $-35.00K and operating cash flow was $-69.28M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.23 | 4.79 | 3.71 | 2.14 | 6.92 |
| Quick Ratio | 3.23 | 4.79 | 3.71 | 2.11 | 6.90 |
| Cash Ratio | 3.06 | 4.34 | 3.33 | 1.93 | 6.72 |
| Solvency Ratio | -2.45 | -4.19 | -4.06 | -3.85 | -4.68 |
| Operating Cash Flow Ratio | -2.19 | -4.75 | -4.80 | -3.70 | -4.68 |
| Short-Term Operating Cash Flow Coverage | -44.10 | -346.70 | -538.52 | 0.00 | -445.43 |
| Net Current Asset Value | $ 128.68M | $ 121.45M | $ 127.05M | $ 88.45M | $ 383.24M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.40 | 1.27 | 1.37 | 1.88 | 1.17 |
| Debt Service Coverage Ratio | -45.02 | -26.08 | -15.28 | -25.83 | -26.61 |
| Interest Coverage Ratio | -6161.91 | -32.18 | -16.00 | -26.54 | -28.87 |
| Debt to Market Cap | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 2.88 | 0.16 | 0.87 | 1.53 | 1.63 |
| Net Debt to EBITDA | 1.33 | 1.04 | 0.82 | 0.50 | 1.41 |
| Profitability Margins | |||||
| Gross Profit Margin | -279.40% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBIT Margin | -615.20% | -15870.52% | -53622.32% | -77583.80% | -39962.66% |
| EBITDA Margin | -566.37% | -15816.75% | -53559.32% | -77356.81% | -39793.15% |
| Operating Profit Margin | -615.20% | -17834.20% | -54186.16% | -78569.41% | -40628.42% |
| Pretax Profit Margin | -673.13% | -16424.76% | -53785.59% | -77666.32% | -39969.51% |
| Net Profit Margin | -673.13% | -16424.76% | -53785.59% | -77666.32% | -39976.36% |
| Continuous Operations Profit Margin | -673.13% | -16424.76% | -53785.59% | -77666.32% | -39969.51% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.02% |
| EBT Per EBIT | 109.42% | 92.10% | 99.26% | 98.85% | 98.38% |
| Return on Assets (ROA) | -75.66% | -89.40% | -109.22% | -181.23% | -68.72% |
| Return on Equity (ROE) | -105.98% | -113.51% | -149.36% | -341.39% | -80.49% |
| Return on Capital Employed (ROCE) | -96.41% | -122.44% | -150.47% | -344.29% | -81.60% |
| Return on Invested Capital (ROIC) | -94.56% | -121.57% | -149.49% | -340.28% | -81.31% |
| Return on Tangible Assets | -75.66% | -89.40% | -109.22% | -181.23% | -68.72% |
| Earnings Yield | -254.85% | -0.48% | -0.44% | -0.46% | -0.17% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.96 | 1.25 | 0.50 | 0.57 | 0.53 |
| Payables Turnover | 5.80 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 1.48 | 0.68 | 0.82 | 9.05 | 0.65 |
| Asset Turnover | 0.11 | 0.01 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.18 | 0.01 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 60.45 | 292.26 | 725.88 | 638.05 | 683.79 |
| Days of Sales Outstanding | 123.38 | 292.26 | 725.88 | 638.05 | 683.79 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 62.93 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 123.38 | 292.26 | 725.88 | 638.05 | 683.79 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -102.32 | -4.34 | -15.73 | -37.31 | -39.57 |
| Free Cash Flow Per Share | -102.41 | -4.34 | -15.73 | -37.31 | -39.57 |
| Dividend Paid and CapEx Coverage Ratio | -1056.62 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -1056.62 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -35.72 | -187.34 | -538.52 | -1048.11 | -186.90 |
| Operating Cash Flow to Sales Ratio | -5.50 | -180.71 | -635.88 | -740.95 | -391.91 |
| Free Cash Flow Yield | -208.58% | -0.53% | -0.52% | -0.44% | -0.17% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.39 | -207.09 | -226.65 | -219.15 | -576.49 |
| Price-to-Sales (P/S) Ratio | 2.64 | 34028.64 | 121903.21 | 170204.61 | 230459.82 |
| Price-to-Book (P/B) Ratio | 0.42 | 235.18 | 338.52 | 748.15 | 464.00 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.48 | -188.31 | -191.71 | -229.71 | -588.04 |
| Price-to-Operating Cash Flow Ratio | -0.48 | -188.31 | -191.71 | -229.71 | -588.04 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 2.95 | 3.43 | 70.76 | -229.26 |
| Enterprise Value Multiple | 0.87 | -214.10 | -226.78 | -219.53 | -577.73 |
| Enterprise Value | -113.21M | 28.72B | 43.00B | 66.06B | 177.94B |
| EV to EBITDA | 0.87 | -214.10 | -226.78 | -219.53 | -577.73 |
| EV to Sales | -4.91 | 33864.33 | 121463.80 | 169819.53 | 229898.75 |
| EV to Free Cash Flow | 0.89 | -187.40 | -191.02 | -229.19 | -586.61 |
| EV to Operating Cash Flow | 0.89 | -187.40 | -191.02 | -229.19 | -586.61 |
| Tangible Book Value Per Share | 118.07 | 3.48 | 8.91 | 11.45 | 50.14 |
| Shareholders’ Equity Per Share | 118.07 | 3.48 | 8.91 | 11.45 | 50.14 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.01 | -0.00 |
| Revenue Per Share | 18.59 | 0.02 | 0.02 | 0.05 | 0.10 |
| Net Income Per Share | -125.13 | -3.95 | -13.30 | -39.11 | -40.36 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.09 | 1.03 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 2.73 | 103.41 | 304.48 | 520.32 | 16.47 |
| SG&A to Revenue | 0.63 | 45.40 | 0.00 | 0.00 | 16.47 |
| Stock-Based Compensation to Revenue | 0.00 | 6.73 | 8.86 | 8.91 | 9.19 |
| Income Quality | 0.82 | 1.10 | 1.18 | 0.95 | 0.98 |
Currency in NOK